Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
European Clinical Respiratory Journal|April 7, 2023
A retrospective study on immune-related pneumonitis in patients with non-small-cell lung cancer undergoing treatment with PD-1/PD-L1 inhibitorsDorthe Yakymenko, Kristin Skougaard
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 11, 2013
Comparison of EORTC criteria and PERCIST for PET/CT response evaluation of patients with metastatic colorectal cancer treated with irinotecan and cetuximabKristin Skougaard, Dorte Nielsen, Benny Vittrup Jensen, et al.
Oncology Letters|July 19, 2012
Impact of third-line treatment with irinotecan plus cetuximab on non-tumor standardized uptake values in patients with metastatic colorectal cancerKim Francis Andersen, Kristin Skougaard, Anne Lerberg Nielsen, et al.
Radiology and Oncology|December 3, 2013
Dual time point imaging fluorine-18 flourodeoxyglucose positron emission tomography for evaluation of large loco-regional recurrences of breast cancer treated with electrochemotherapyLouise Wichmann Matthiessen, Helle Hjorth Johannesen, Kristin Skougaard, et al.
Acta Oncologica (Stockholm, Sweden)|August 23, 2016
Early <sup>18</sup>F-FDG-PET/CT as a predictive marker for treatment response and survival in patients with metastatic colorectal cancer treated with irinotecan and cetuximabKristin Skougaard, Dorte Nielsen, Benny Vittrup Jensen, et al.
Physics and Imaging in Radiation Oncology|September 2, 2025
Exploring hypoxia in head and neck cancer through blood perfusion and metabolism using dual-energy computed tomography and positron emission tomographyJens Edmund, Christian Maare, Henriette Klitgaard Mortensen, et al.
Acta Oncologica (Stockholm, Sweden)|March 22, 2012
Observer variability in a phase II trial - assessing consistency in RECIST applicationKristin Skougaard, Mark James Dusgaard McCullagh, Dorte Nielsen, et al.
Cancer Medicine|June 20, 2014
CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximabKristin Skougaard, Helle Hjorth Johannesen, Dorte Nielsen, et al.
Basic & Clinical Pharmacology & Toxicology|September 30, 2011
Impact of ABCB1 variants on neutrophil depression: a pharmacogenomic study of paclitaxel in 92 women with ovarian cancerTroels K Bergmann, Charlotte Brasch-Andersen, Henrik Gréen, et al.
Acta Oncologica (Stockholm, Sweden)|May 3, 2011
Bevacizumab in combination with cetuximab and irinotecan after failure of cetuximab and irinotecan in patients with metastatic colorectal cancerFinn Ole Larsen, Per Pfeiffer, Dorte Nielsen, et al.
Pageof 2